PT - JOURNAL ARTICLE AU - Santo, Tiffany Dal AU - Rice, Danielle B. AU - Carrier, Marie-Eve AU - Virgili-Gervais, Gabrielle AU - Levis, Brooke AU - Kwakkenbos, Linda AU - Bartlett, Susan J. AU - Gietzen, Amy AU - Gottesman, Karen AU - Guillot, Geneviève AU - Hudson, Marie AU - Hummers, Laura K. AU - Malcarne, Vanessa L. AU - Mayes, Maureen D. AU - Mouthon, Luc AU - Richard, Michelle AU - Sauvé, Maureen AU - Wojeck, Robyn K. AU - Geoffroy, Marie-Claude AU - Benedetti, Andrea AU - Thombs, Brett D. AU - , TI - Factors Associated with Physical Function among People with Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort Cross-sectional Study AID - 10.1101/2023.08.23.23294495 DP - 2023 Jan 01 TA - medRxiv PG - 2023.08.23.23294495 4099 - http://medrxiv.org/content/early/2023/08/24/2023.08.23.23294495.short 4100 - http://medrxiv.org/content/early/2023/08/24/2023.08.23.23294495.full AB - Objectives To compare physical function in systemic sclerosis (SSc, scleroderma) to general population normative data and identify associated factors.Methods Scleroderma Patient-centered Intervention Network Cohort participants completed the Physical Function domain of the Patient-Reported Outcomes Measurement Information System Version 2 upon enrollment. Multivariable linear regression was used to assess associations of sociodemographic, lifestyle, and disease-related variables.Results Among 2,385 participants, mean physical function T-score (43.7, SD = 8.9) was approximately 2/3 of a standard deviation (SD) below the US general population (mean = 50, SD = 10). Factors associated in multivariable analysis included older age (-0.74 points per SD years, 95% CI -0.78 to -1.08), female sex (-1.35, -2.37 to -0.34), fewer years of education (-0.41 points per SD in years, -0.75 to -0.07), being single, divorced, or widowed (-0.76, -1.48 to -0.03), smoking (-3.14, -4.42 to -1.85), alcohol consumption (0.79 points per SD drinks per week, 0.45 to 1.14), BMI (-1.41 points per SD, -1.75 to -1.07), diffuse subtype (-1.43, -2.23 to -0.62), gastrointestinal involvement (-2.58, -3.53 to -1.62), digital ulcers (-1.96, -2.94 to -0.98), moderate (-1.94, -2.94 to -0.93) and severe (-1.76, -3.24 to -0.28) small joint contractures, moderate (-2.10, -3.44 to -0.76) and severe (-2.54, -4.64 to -0.44) large joint contractures, interstitial lung disease (-1.52, -2.27 to -0.77); pulmonary arterial hypertension (-3.72, -4.91 to -2.52); rheumatoid arthritis (-2.10, -3.64 to -0.56) and idiopathic inflammatory myositis (-2.10, -3.63 to -0.56).Conclusion Physical function is impaired for many individuals with SSc and associated with multiple disease factors.KEY MESSAGESIndividuals with systemic sclerosis (SSc) face many challenges that can impact their physical functionLevels of physical function in individuals with SSc are impaired compared to the general populationMultiple disease factors are significantly associated with worse physical function in SScCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThe Scleroderma Patient-centered Intervention Network (SPIN) Cohort has received funding from the Canadian Institutes of Health Research (CIHR); the Lady Davis Institute for Medical Research of the Jewish General Hospital, Montreal, Quebec, Canada; the Jewish General Hospital Foundation, Montreal, Quebec, Canada; and McGill University, Montreal, Quebec, Canada. SPIN has also received support from the Scleroderma Society of Ontario; Scleroderma Canada; Sclerodermie Quebec; Scleroderma Manitoba; Scleroderma Atlantic; the Scleroderma Association of BC; Scleroderma SASK; Scleroderma Australia; Scleroderma New South Wales; Scleroderma Victoria; and Scleroderma Queensland. TDS was supported by a CIHR Masters Award and MCG and BDT by Canada Research Chairs, all outside of the present work. No sponsor had any role in the study design; in the collection, analysis and interpretation of the data; in the writing of the report; or in the decision to submit the paper for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The SPIN Cohort study was approved by the Research Ethics Committee of the Centre integre universitaire de sante et de services sociaux du Centre-Ouest-de-l'Ile-de-Montreal (#MP-05-2013-150) and by the ethics committees of all recruiting sites.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes